Helicobacter pylori eradication: influence of interleukin-1beta –31 C/T polymorphism
Open Access
- 24 July 2018
- journal article
- research article
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 22 (4) , 311-316
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Diagnosis and Epidemiology of Helicobacter pylori InfectionHelicobacter, 2013
- Helicobacter pylori infection in functional dyspepsiaNature Reviews Gastroenterology & Hepatology, 2013
- Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)Cancer Causes & Control, 2012
- Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus ReportGut, 2012
- WINPEPI updated: computer programs for epidemiologists, and their teaching potentialEpidemiologic Perspectives & Innovations, 2011
- Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pyloriJournal of Gastroenterology and Hepatology, 2009
- Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapyArchivum Immunologiae et Therapiae Experimentalis, 2009
- Polymorphism of interleukin-1β affects the eradication rates of Helicobacter pylori by triple therapyClinical Gastroenterology and Hepatology, 2004
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000
- Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus ReportEuropean Journal of Gastroenterology & Hepatology, 1997